Back to Rankings

GNPX

GenprexD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
In line
vs peer average
GNPX vs peer average
48/100
GNPX vs. peer average (D vs. D)
Grade spread
A 1 · B 1 · C 1 · F 5
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

ASBP is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $7.8M

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerASBPAspire Biopharma
GNPX
Genprex
ASBP
Aspire Biopharma
Grade
D
F
Momentum
49
1
Value
41
42
Sentiment
-
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Defensive

Grade position vs ASBP

GNPX / ASBP
Grade Position
In line
GNPX vs. peer average (D vs. D)
48/100
Momentum
49
GNPX
Value
41
ASBP
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs GNPX
1
ASBP
Aspire Biopharma Holdings Inc Common
F
20/100
+1
2
XBIO
Xenetic Biosciences Inc Common
C
60/100
-1
3
ACXP
Acurx Pharmaceuticals Inc Common
F
20/100
+1
4
BIAF
bioAffinity Technologies Inc Common
A
100/100
-3
5
APM
Aptorum Group Ltd Class A Common
F
20/100
+1
ASBP is the first peer returned for this comparison set.